Making it Possible September 2019 Forward-Looking Statements 1 Except for historical information, all of the statements, expectations, and assumptions contained in this presentation are forward-looking statements. Forward-looking statements include, but are not limited to, statements that express our intentions, beliefs, expectations, strategies, predictions or any other statements relating to our future activities or other future events or conditions. These statements are based on current expectations, est ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: June 30, 2019 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _________________ to ______________________ COMMISSION FILE NUMBER: 001-38365 EYENOVIA, INC. (Exact name of Registrant as Specified in Its Charter) | --- | --- | |-------- ...

Eyenovia, Inc. (NASDAQ:EYEN) Q2 2019 Results Earnings Conference Call August 12, 2019 4:30 PM ET Company Participants Tram Bui - The Ruth Group Sean Ianchulev - CEO and Chief Medical Officer John Gandolfo - CFO Conference Call Participants Matt Kaplan - Ladenburg Thalmann Yi Chen - H.C. Wainwright Operator Good day, ladies and gentlemen. Thank you for standing by. And welcome to Eyenovia, Inc. Second Quarter 2019 Earnings Conference Call. [Operator Instructions] As a reminder, this conference may be recorde ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: March 31, 2019 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _________________ to ______________________ COMMISSION FILE NUMBER: 001-38365 EYENOVIA, INC. (Exact name of Registrant as Specified in Its Charter) DELAWARE 47-1178401 (S ...

Eyenovia, Inc. (NASDAQ:EYEN) Q1 2019 Earnings Conference Call May 14, 2019 8:30 AM ET Company Participants Tram Bui - The Ruth Group Sean Ianchulev - CEO, President, Chief Medical Officer & Director John Gandolfo - CFO & Secretary Conference Call Participants Esther Rajavelu - Oppenheimer Maria Barbera - Ladenburg Thalmann & Co. Yi Chen - H.C. Wainwright & Co. Jonathan Aschoff - National Securities Corporation Operator Good morning, ladies and gentlemen, and welcome to the Eyenovia First Quarter 2019 Earnin ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended: December 31, 2018 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _________________ to ______________________ COMMISSION FILE NUMBER: 001-38365 EYENOVIA, INC. | --- | --- | |--------------------------------------------------|---------------- ...

Eyenovia, Inc. (NASDAQ:EYEN) Q4 2018 Earnings Conference Call March 27, 2019 8:30 AM ET Company Participants Tram Bui - The Ruth Group Sean Ianchulev - CEO & Chief Medical Officer John Gandolfo - CFO Conference Call Participants Matt Kaplan - Ladenburg Thalmann Scott Henry - ROTH Capital Jonathan Aschoff - National Securities Yi Chen - H.C. Wainwright Operator Good day ladies and gentlemen and welcome to the Eyenovia Fourth Quarter and Full Year 2018 Earnings Conference Call. At this time, all participants ...